Jennifer E Van Eyk

This inventor holds 30 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Biomarker Assays. Top assignees: Johns Hopkins University, Cedars-Sinai Medical Center, Queen's University at Kingston. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer E Van Eyk. Retrieved from https://idiyas.com/inventor/jennifer-e-van-eyk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 17)

% Patents Active = 83.3

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 17)

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 36(Granted Patents)

Location History:

Kingston, CA (2004 - 2009)
Baltimore, MD (US) (2007 - 2024)
Los Angeles, CA (US) (2017 - 2024)

Company Filing History:

17 out of 3,801

Johns Hopkins University

patents

8 out of 628

Cedars-Sinai Medical Center

patents

7 out of 424

Queen's University at Kingston

patents

4. 1 out of 4,188

Abbott Laboratories Corporation

patents

5. 1 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6. 1 out of 1

Vu-Vumc IP Management Bv

patent

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Biomarkers

Protein Assay

Mitochondrial Proteins

Chronic Kidney Disease

Brain Injury

Cardiovascular Disease

Mass Spectrometry

Peptide Antibody Depletion

Myocardial Injury

Diagnostic Assay

Neurodegeneration

Ischemia

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12535489 - MULTIPLEXED PROTEIN ASSAY FOR THE DETECTION OF MITOCHONDRIAL PROTEIN SIGNATURES (2026-01-27),

2. 12339288 - Multi-protein biomarker assay for brain injury detection and outcome (2025-06-24),

3. 12174201 - Prognosis and progression biomarkers for chronic kidney disease (2024-12-24),

4. 12007395 - Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration (2024-06-11),

5. 11994523 - Biomarkers and methods for diagnosing and evaluating traumatic brain injury (2024-05-28),

6. 11499982 - Multi-protein biomarker assay for brain injury detection and outcome (2022-11-15),

7. 11193947 - B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment (2021-12-07),

8. 11105817 - Role of citrullination in diagnosing diseases (2021-08-31),

9. 11041865 - Biomarkers of myocardial injury (2021-06-22),

10. 10534003 - Multi-protein biomarker assay for brain injury detection and outcome (2020-01-14),

11. 10393754 - Methods of diagnosing and treating heart failure (2019-08-27),

12. 10365288 - Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration (2019-07-30),

13. 10352942 - Correlated peptides for quantitative mass spectrometry (2019-07-16),

14. 10309974 - Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease (2019-06-04),

15. 9746481 - Biomarkers of brain injury (2017-08-29),

Title: Jennifer E Van Eyk - Innovator from Baltimore

Introduction: Jennifer E Van Eyk is a pioneering inventor based in Baltimore, MD, known for her groundbreaking contributions to the field of biotechnology and medical devices.

Latest Patents: Jennifer E Van Eyk holds several patents related to innovative diagnostic tools and medical technologies that have revolutionized the healthcare industry.

Career Highlights: With a career spanning over two decades, Jennifer E Van Eyk has worked tirelessly to develop cutting-edge solutions for early disease detection and personalized medicine. Her work has been instrumental in improving patient outcomes and advancing medical research.

Collaborations: Throughout her career, Jennifer E Van Eyk has collaborated with leading researchers, healthcare professionals, and industry experts to bring her inventions from concept to reality. Her collaborative approach has led to the successful implementation of her innovative technologies in clinical settings.

Conclusion: Jennifer E Van Eyk's passion for innovation and commitment to improving healthcare have established her as a prominent figure in the field of biotechnology. Her contributions continue to inspire the next generation of inventors and researchers in their quest to make a positive impact on society.

Profile summary based on public USPTO records.